Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 124

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 124
---
8.2%                        |     | —        |     | —     |     | 87.7%                       |     | —        |     | —     |     | —                           |     | —        |     | —     |
| Ranjeev Krishana                    |     | —                           |     | —        |     | —     |     | —                           |     | —        |     | —     |     | —                           |     | —        |     | —     |
| Average pay of employees as a whole |     | 10.1%                       |     | 15.4%    |     | 1.0%  |     | 7.9%                        |     | 10.8%    |     | 18.3% |     | 13.1%                       |     | 13.8%    |     | 19.1% |

A-24

TABLE OF CONTENTS

Relative Importance of the Spend on Pay The table below illustrates the Company’s expenditure on pay, in comparison to Group’s expenditure on research and development costs. Research and Development is the company’s principal activity and, as such, is the most appropriate metric against which to measure employee expenditure given there have been no distributions to shareholders by way of dividend or share buyback.

|                                      |     |      2024 
 ($000)(2) |     |      2023 
 ($000)(2) |
| Group research and development costs |     |   217,658 |     |   160,971 |
| Total employee pay expenditure       |     |   120,884 |     |   101,877 |

| (1) | Total employee pay expenditure includes wages and salaries, social security costs, GUID contributions, bonus and share-based compensation charge. |

| (2) | For remuneration not paid in U.S. dollars, amounts in pounds sterling have been translated for convenience to U.S. dollars at a rate of 1.2781 (2023: 1.2400). |

The above table reflects expenditure for the full year. Chief Executive Officer Pay Ratio These ratios set out the comparison between the CEO’s remuneration and that for employees in the UK for the full years ended 31 December 2024, 2023, 2022, and 2021. 2021 was the first year that the Company prepared a Remuneration Report as the Company was incorporated on 7 January